These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 23960185)
1. Pancreatic cancer clinical trials and accrual in the United States. Hoos WA; James PM; Rahib L; Talley AW; Fleshman JM; Matrisian LM J Clin Oncol; 2013 Sep; 31(27):3432-8. PubMed ID: 23960185 [TBL] [Abstract][Full Text] [Related]
2. Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP program. Lyss AP; Lilenbaum RC Clin Lung Cancer; 2009 Nov; 10(6):410-3. PubMed ID: 19900858 [TBL] [Abstract][Full Text] [Related]
3. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. Newman LA; Hurd T; Leitch M; Kuerer HM; Diehl K; Lucci A; Giuliano A; Hunt KK; Putnam W; Wells SA J Am Coll Surg; 2004 Oct; 199(4):644-51. PubMed ID: 15454152 [TBL] [Abstract][Full Text] [Related]
4. Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group. Galsky MD; Hendricks R; Svatek R; Bangs R; Hoffman-Censits J; Clement J; Dreicer R; Guancial E; Hahn N; Lerner SP; O'Donnell PH; Quale DZ; Siefker-Radtke A; Shipley W; Sonpavde G; Vaena D; Vinson J; Rosenberg J Cancer; 2013 Jun; 119(11):1994-8. PubMed ID: 23456777 [TBL] [Abstract][Full Text] [Related]
5. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? Yee KW; Pater JL; Pho L; Zee B; Siu LL J Clin Oncol; 2003 Apr; 21(8):1618-23. PubMed ID: 12697888 [TBL] [Abstract][Full Text] [Related]
6. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. Sateren WB; Trimble EL; Abrams J; Brawley O; Breen N; Ford L; McCabe M; Kaplan R; Smith M; Ungerleider R; Christian MC J Clin Oncol; 2002 Apr; 20(8):2109-17. PubMed ID: 11956272 [TBL] [Abstract][Full Text] [Related]
7. Clinical trial accrual among new cancer patients at a community-based cancer center. Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates. Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138 [TBL] [Abstract][Full Text] [Related]
9. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. Kimmick GG; Peterson BL; Kornblith AB; Mandelblatt J; Johnson JL; Wheeler J; Heinze R; Cohen HJ; Muss HB J Clin Oncol; 2005 Apr; 23(10):2201-7. PubMed ID: 15800312 [TBL] [Abstract][Full Text] [Related]
10. Enrollment in clinical cancer trials: how are we doing and what are the obstacles to improving enrollment rates? A 2-year retrospective review of pediatric cancer trial enrollment in New Zealand. Dodgshun AJ; De Silva MP; Bradbeer P; Cross S J Pediatr Hematol Oncol; 2014 Nov; 36(8):630-4. PubMed ID: 24577541 [TBL] [Abstract][Full Text] [Related]
11. Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. Li J; Ng J; Allendorf J; Saif MW JOP; 2011 Jul; 12(4):347-50. PubMed ID: 21737893 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic neoplasm in 2011: an update. Saif MW JOP; 2011 Jul; 12(4):316-21. PubMed ID: 21737886 [TBL] [Abstract][Full Text] [Related]
13. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Newman LA; Lee CT; Parekh LP; Stewart AK; Thomas CR; Beltran RA; Lucci A; Green B; Ota D; Nelson H; Cancer; 2006 Jan; 106(1):188-95. PubMed ID: 16333856 [TBL] [Abstract][Full Text] [Related]
14. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual. Klabunde C; Kaluzny A; Ford L Cancer Epidemiol Biomarkers Prev; 1995; 4(7):783-9. PubMed ID: 8672997 [TBL] [Abstract][Full Text] [Related]
15. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736 [TBL] [Abstract][Full Text] [Related]
17. The effects of managed care and competition on community-based clinical research. Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362 [TBL] [Abstract][Full Text] [Related]
18. Obstacles to the accrual of patients to clinical trials in the community setting. Winn RJ Semin Oncol; 1994 Aug; 21(4 Suppl 7):112-7. PubMed ID: 8091236 [TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant therapy for resectable pancreatic cancer. Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939 [TBL] [Abstract][Full Text] [Related]
20. Accrual to Trans-Tasman Radiation Oncology Group-sponsored trials 2010-2012. Christie DR J Med Imaging Radiat Oncol; 2013 Aug; 57(4):499-502. PubMed ID: 23870351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]